|
1
|
ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.
|
J Clin Oncol
|
2005
|
1.87
|
|
2
|
First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trial.
|
J Clin Oncol
|
2011
|
1.84
|
|
3
|
Azacitidine for the treatment of patients with acute myeloid leukemia: report of 82 patients enrolled in an Italian Compassionate Program.
|
Cancer
|
2011
|
1.67
|
|
4
|
Plerixafor added to chemotherapy plus G-CSF is safe and allows adequate PBSC collection in predicted poor mobilizer patients with multiple myeloma or lymphoma.
|
Biol Blood Marrow Transplant
|
2011
|
1.66
|
|
5
|
Long-term follow-up analysis of HD9601 trial comparing ABVD versus Stanford V versus MOPP/EBV/CAD in patients with newly diagnosed advanced-stage Hodgkin's lymphoma: a study from the Intergruppo Italiano Linfomi.
|
J Clin Oncol
|
2011
|
1.61
|
|
6
|
Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage.
|
Blood
|
2008
|
1.52
|
|
7
|
An artificial di-iron oxo-protein with phenol oxidase activity.
|
Nat Chem Biol
|
2009
|
1.37
|
|
8
|
Bio-objects' political capacity: a research agenda.
|
Croat Med J
|
2013
|
1.35
|
|
9
|
Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-cell lymphoma with a poor prognosis: a phase II multicenter study.
|
Haematologica
|
2009
|
1.15
|
|
10
|
Artificial diiron proteins: from structure to function.
|
Biopolymers
|
2005
|
1.12
|
|
11
|
Preorganization of molecular binding sites in designed diiron proteins.
|
Proc Natl Acad Sci U S A
|
2003
|
1.12
|
|
12
|
Sliding helix and change of coordination geometry in a model di-MnII protein.
|
Angew Chem Int Ed Engl
|
2003
|
1.04
|
|
13
|
Final results of a multicenter trial addressing role of CSF flow cytometric analysis in NHL patients at high risk for CNS dissemination.
|
Blood
|
2012
|
1.00
|
|
14
|
Structure-based design of an urokinase-type plasminogen activator receptor-derived peptide inhibiting cell migration and lung metastasis.
|
Mol Cancer Ther
|
2009
|
0.95
|
|
15
|
Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated, elderly patients with diffuse large B-cell lymphoma: a phase I study by the Fondazione Italiana Linfomi.
|
Haematologica
|
2013
|
0.94
|
|
16
|
Artificial di-iron proteins: solution characterization of four helix bundles containing two distinct types of inter-helical loops.
|
J Biol Inorg Chem
|
2005
|
0.92
|
|
17
|
Design and characterization of a peptide mimotope of the HIV-1 gp120 bridging sheet.
|
Int J Mol Sci
|
2012
|
0.87
|
|
18
|
Single amino acid substitutions in the chemotactic sequence of urokinase receptor modulate cell migration and invasion.
|
PLoS One
|
2012
|
0.86
|
|
19
|
Molecular engineering of RANTES peptide mimetics with potent anti-HIV-1 activity.
|
FASEB J
|
2011
|
0.86
|
|
20
|
Crystal and Molecular Structure of the [6-Deoxy-6-[(2-(4-imidazolyl)ethyl)amino]- cyclomaltoheptaose]copper(II) Ternary Complex with L-Tryptophanate. Role of Weak Forces in the Chiral Recognition Process Assisted by a Metallocyclodextrin.
|
Inorg Chem
|
1996
|
0.86
|
|
21
|
A urokinase receptor-derived peptide inhibiting VEGF-dependent directional migration and vascular sprouting.
|
Mol Cancer Ther
|
2013
|
0.84
|
|
22
|
An urokinase receptor antagonist that inhibits cell migration by blocking the formyl peptide receptor.
|
FEBS Lett
|
2008
|
0.84
|
|
23
|
Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross-talk in the bone marrow of multiple myeloma patients.
|
J Pathol
|
2012
|
0.84
|
|
24
|
Factors affecting successful mobilization with plerixafor: an Italian prospective survey in 215 patients with multiple myeloma and lymphoma.
|
Transfusion
|
2013
|
0.83
|
|
25
|
Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study.
|
Hematol Oncol
|
2012
|
0.83
|
|
26
|
Critical role of the N-loop and beta1-strand hydrophobic clusters of RANTES-derived peptides in anti-HIV activity.
|
Biochem Biophys Res Commun
|
2006
|
0.82
|
|
27
|
Evaluation of the oligosaccharide composition of commercial follicle stimulating hormone preparations.
|
Electrophoresis
|
2013
|
0.81
|
|
28
|
MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
|
Clin Cancer Res
|
2006
|
0.81
|
|
29
|
UPARANT: a urokinase receptor-derived peptide inhibitor of VEGF-driven angiogenesis with enhanced stability and in vitro and in vivo potency.
|
Mol Cancer Ther
|
2014
|
0.79
|
|
30
|
Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma.
|
Angiogenesis
|
2013
|
0.79
|
|
31
|
The role of anthracyclines in combination chemotherapy for the treatment of follicular lymphoma: retrospective study of the Intergruppo Italiano Linfomi on 761 cases.
|
Leuk Lymphoma
|
2003
|
0.78
|
|
32
|
Outcome of Very Late Relapse in Patients with Hodgkin's Lymphomas.
|
Adv Hematol
|
2010
|
0.78
|
|
33
|
Redox and electrocatalytic properties of mimochrome VI, a synthetic heme peptide adsorbed on gold.
|
Langmuir
|
2010
|
0.77
|
|
34
|
Spectroscopic and metal-binding properties of DF3: an artificial protein able to accommodate different metal ions.
|
J Biol Inorg Chem
|
2010
|
0.77
|
|
35
|
Artificial heme-proteins: determination of axial ligand orientations through paramagnetic NMR shifts.
|
Chem Commun (Camb)
|
2014
|
0.76
|
|
36
|
An artificial heme-enzyme with enhanced catalytic activity: evolution, functional screening and structural characterization.
|
Org Biomol Chem
|
2015
|
0.75
|
|
37
|
Miniaturized heme proteins: crystal structure of Co(III)-mimochrome IV.
|
J Biol Inorg Chem
|
2004
|
0.75
|
|
38
|
Design of a new mimochrome with unique topology.
|
Chemistry
|
2003
|
0.75
|
|
39
|
De novo design, synthesis and characterisation of MP3, a new catalytic four-helix bundle hemeprotein.
|
Chemistry
|
2012
|
0.75
|
|
40
|
A heme-peptide metalloenzyme mimetic with natural peroxidase-like activity.
|
Chemistry
|
2011
|
0.75
|
|
41
|
[Patients, consumers or neither: narratives and positions of women in the case of preimplantation diagnosis in Spanish State].
|
Rev Derecho Genoma Hum
|
2014
|
0.75
|
|
42
|
A FRET-based biosensor for NO detection.
|
J Inorg Biochem
|
2010
|
0.75
|